Serina Therapeutics, Inc. has announced that it will hold its Annual Meeting of Stockholders on November 7, 2025. During the meeting, stockholders will vote on the election of Class II directors, the ratification of the appointment of independent registered public accountants, and the approval of the issuance of common stock in connection with the exercise of certain Convertible Note and Warrants. Other business may also be transacted as may properly come before the meeting or any adjournments thereof. The meeting will be held virtually.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001708599-25-000115), on September 26, 2025, and is solely responsible for the information contained therein.